COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,864 Articles (22,568 medRxiv, 8,296 bioRxiv)

Most recent first Previous |  Page 2150: Articles 21491-21500  | Next

Autoproteolytic Products of the SARS-CoV-2 Nucleocapsid Protein are Primed for Antibody Evasion and Virus Proliferation
Lutomski, C. A., El-Baba, T. J., Bolla, J. R., Robinson, C. V.
10.1101/2020.10.06.328112 — Posted: 2020-10-06 Discussion: Onsite
Systematic discovery and functional interrogation of SARS-CoV-2 viral RNA-host protein interactions during infection
Flynn, R. A., Belk, J. A., Qi, Y., Yasumoto, Y., Schmitz, C. O., Mumbach, M. R., Limaye, A., Wei, J., Alfajaro, M. M., Parker, K. R., Chang, H. Y., Horvath, T. L., Carette, J. E., Bertozzi, C., Wilen, C. B., Satpathy, A. T.
10.1101/2020.10.06.327445 — Posted: 2020-10-06
An in-depth investigation of the safety and immunogenicity of an inactivated SARS-CoV-2 vaccine
Pu, J., Yu, Q., Yin, Z., Zhang, Y., Li, X., Li, D., Chen, H., Long, R., Zhao, Z., Mou, T., Zhao, H., Feng, S., Xie, Z., Wang, L., He, Z., Liao, Y., Fan, S., Yin, Q., Jiang, R., Wang, J., Zhang, L., Li, J., Zheng, H., Cui, P., Jiang, G., Guo, L., Xu, M., Yang, H., Lu, S., Wang, X., Gao, Y., Xu, X., Cai, L., Zhou, J., Yu, L., Chen, Z., Hong, C., Du, D., Zhao, H., Li, Y., Ma, K., Ma, Y., Liu, D., Yao, S., Li, C., Che, Y., Liu, L., Li, Q.
10.1101/2020.09.27.20189548 — Posted: 2020-10-06 Discussion: Offsite
Epidemic characteristics of respiratory viruses in hospitals in a Chinese city during the SARS-CoV-2 epidemic
Yang, W., Chen, J., Xu, M., Wang, J., Li, H., Wang, Y.
10.1101/2020.10.06.20207589 — Posted: 2020-10-06
SARS-CoV-2 Inactivation Potential of Metal Organic Framework Induced Photocatalysis
Ornstein, J. M., Ozdemir, R., Boehme, A., Serre, C., Nouar, F., Santarpia, J., Herrera, V. L., Ackerman, D. N.
10.1101/2020.10.01.20204214 — Posted: 2020-10-06
Consideration for the asymptomatic transmission of COVID-19: Systematic Review and Meta-Analysis
Ravindra, K., Malik, V. S., Padhi, B. K., Goel, S., Gupta, M.
10.1101/2020.10.06.20207597 — Posted: 2020-10-06
Highly Effective Inactivation of SARS-CoV-2 by Conjugated Polymers and Oligomers
Schanze, K. S., Whitten, D. G., Kell, A. M., Chi, E. Y., Ista, L. K., Monge, F. A., Jagadesan, P., Bondu, V., Donabedian, P. L.
10.1101/2020.09.29.20204164 — Posted: 2020-10-06
Pathogenesis-based pre-exposure prophylaxis associated with low risk of SARS-CoV-2 infection in healthcare workers at a designated Covid-19 hospital
Dubina, M. V., Gomonova, V. V., Taraskina, A. E., Vasilyeva, N. V., Sayganov, S. A.
10.1101/2020.09.25.20199562 — Posted: 2020-10-06
Which factors should be included in triage? An online survey of the attitudes of the UK general public to pandemic triagedilemmas
Wilkinson, D., Zohny, H., Kappes, A., Sinnott-Armstrong, W., Savulescu, J.
10.1101/2020.10.06.20207662 — Posted: 2020-10-06
Characteristics and outcomes of hospitalized adults with COVID-19 in Nepal: a multicenter, prospective cohort study
Chaudhary, A., Singh, U. N., Paudel, P., Thapa, N., Khadka, K., Sah, P. K., Kamar, S. B., Joshi, J., Ansari, K. H., Tiwari, S. R., Sharma, S., Jaiswal, S. K., Joshi, R., Baskota, S., Tiwari, A. P., Pandey, H. R.
10.1101/2020.10.03.20206128 — Posted: 2020-10-06

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).